Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Liver function may change how lung cancer drug works

NCT ID NCT07538973

First seen Apr 28, 2026 · Last updated May 22, 2026 · Updated 2 times

Summary

This study looks at how the body processes a lung cancer drug called anecatibin in people with different levels of liver function. It will compare 24 adults with and without liver impairment to measure drug levels and safety. The goal is to gather information, not to treat the disease directly.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LUNG CANCER are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Qingdao University Affiliated Hospital

    Qingdao, Shandong, 266000, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Xiamen Traditional Chinese Medicine Hospital

    Xiamen, Fujian, 361000, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Zhengzhou Sixth People's Hospital

    Zhengzhou, Henan, 450015, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.